Combined diet and exercise training decreases serum lipids associated with insulin resistance
Obesity · 2024-12 · 32 (12) · 2334-2344
DOI: 10.1002/oby.24156 ↗Kurz gefasst
Fachartikel in der Zeitschrift Obesity, online erschienen am 26.11.2024. Verfasst von Josiane L Broussard und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Metabolism, and Diabetes, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA. Hauptthemen laut MEDLINE: Insulin Resistance, Exercise, Obesity, Triglycerides. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, NIDDK NIH HHS, American Diabetes Association.
Abstract (Originalsprache)
Objective
Circulating lipids are linked with insulin resistance and increased cardiovascular disease risk. We previously reported that dihydroceramides, a specific type of sphingolipid, are elevated in insulin‐resistant individuals; however, little is known regarding whether insulin‐sensitizing lifestyle interventions can improve profiles of sphingolipids and other lipid species.
Methods
A total of 21 individuals with obesity participated in a 3‐month lifestyle intervention of combined weight loss and exercise training. Insulin sensitivity was assessed by hyperinsulinemic‐euglycemic clamps, and serum lipidomics was conducted.
Results
Following the intervention, BMI was significantly reduced by 10%; VO 2 peak and insulin sensitivity increased by 12% and 57%, respectively; and total serum triacylglycerol (TAG), diacylglycerol, dihydroceramides, sphingosine‐1‐phosphate, and sphinganine‐1‐phosphate were significantly reduced, as were specific species of dihydroceramides (C18:0 and C24:1). Individuals with higher preintervention TAG concentrations had significant decreases in serum lipids, which were not significantly changed in individuals with lower preintervention TAG.
Conclusions
These data show that serum sphingolipid species previously linked to insulin resistance in humans can be reduced with insulin‐sensitizing lifestyle interventions. Furthermore, individuals with elevated serum TAG may significantly benefit from lifestyle interventions that increase insulin sensitivity due to a greater decrease in serum lipids related to insulin resistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Endocrinology, Metabolism, and Diabetes, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
- Department of Health and Exercise Science, Colorado State University, Fort Collins, Colorado, USA.
- Eli Lilly and Company, Indianapolis, Indiana, USA.
- School of Exercise, Sport, and Health Sciences, Oregon State University, Corvallis, Oregon, USA.
ORCID-Profile: Josiane L Broussard, Leigh Perreault
Förderung
- NIH HHS
- NIDDK NIH HHS
- American Diabetes Association
- NCRR NIH HHS
- National Institutes of Health Clinical Translational Research Center
- National Institutes of Health
Zitieren
APA
Broussard, J. L., Garfield, A., Zarini, S., Brozinick, J. T., Perreault, L., Newsom, S. A., Kahn, D., Kerege, A., Berry, K. Z., Bui, H. H., & Bergman, B. C. (2024). Combined diet and exercise training decreases serum lipids associated with insulin resistance. Obesity, 32(12), 2334-2344. https://doi.org/10.1002/oby.24156
Vancouver
Broussard JL, Garfield A, Zarini S, Brozinick JT, Perreault L, Newsom SA, et al. Combined diet and exercise training decreases serum lipids associated with insulin resistance. Obesity. 2024;32(12):2334-2344. doi:10.1002/oby.24156
BibTeX
@article{Broussard2024,
author = {Broussard, Josiane L and Garfield, Amanda and Zarini, Simona and Brozinick, Joseph T and Perreault, Leigh and Newsom, Sean A and Kahn, Darcy and Kerege, Anna and Berry, Karin Zemski and Bui, Hai Hoang and Bergman, Bryan C},
title = {Combined diet and exercise training decreases serum lipids associated with insulin resistance},
journal = {Obesity},
year = {2024},
volume = {32},
number = {12},
pages = {2334--2344},
doi = {10.1002/oby.24156}
}
EUVIMED